ArticleBMC infectious diseases2025
Infertility treatment-associated Abiotrophia defectiva endocarditis with positive PR3-ANCA: a case report.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a rare case of a 41-year-old woman with Abiotrophia defectiva infective endocarditis (IE) after infertility treatment, mimicking ANCA-associated vasculitis. A. defectiva is a nutritionally variant streptococcus found in human microbiota, rarely causing IE. The patient had undergone four unsuccessful oocyte retrieval cycles and discontinued treatment. One week later, she developed lower back pain, night sweats, and persistent cold-like symptoms. Initial blood tests revealed elevated inflammatory markers, anemia, and PR3-ANCA positivity, leading to a misdiagnosis of ANCA-associated vasculitis and treatment with prednisolone. Shortly after, the patient presented with worsening symptoms. Echocardiography revealed mitral valve destruction with severe regurgitation, vegetation, and pericardial effusion. MRI identified cerebellar infarction and subarachnoid hemorrhage. Emergency mitral valve replacement with a bioprosthesis was performed due to extensive valvular destruction. Blood cultures and intraoperative valve cultures confirmed A. defectiva. Preoperative antibiotic therapy included meropenem and vancomycin, which were later de-escalated to ceftriaxone for six weeks. The patient’s recovery was uneventful, with normalized inflammatory markers, and PR3-ANCA levels. At 12-month follow-ups, she remained asymptomatic with no evidence of ANCA-associated disease. This case underscores the challenges of diagnosing A. defectiva IE due to overlapping clinical features with ANCA-associated vasculitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.